This pharmaceutical company is a leading player in the Baltic States with a global reach, focusing on the development and production of a wide range of pharmaceutical products. Their portfolio includes prescription medications, over-the-counter drugs, and active pharmaceutical ingredients (APIs). They have a strong presence in key regions like the EU and North America, with production lines dedicated to various therapeutic areas including heart health, diabetes, central nervous system disorders, and oncology. The company emphasizes quality assurance through GMP certifications and holds several product patents.